Life-threatening hypothermia in Parkinson's disease

Movement Disorders

Volumn 24, Issue 6, 2009, Pages 945-946

  Hama, Kiwa ^a   Miwa, Hideto ^a   Kondo, Tomoyoshi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; CARBIDOPA PLUS LEVODOPA; QUETIAPINE; SODIUM CHLORIDE;

ADULT; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ELECTRIC BLANKET; HUMAN; HYPERTHERMIC THERAPY; HYPOTHERMIA; LETTER; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; STUPOR; TACHYCARDIA; TREATMENT DURATION; UNCONSCIOUSNESS; VISUAL HALLUCINATION;

HUMANS; HYPOTHERMIA; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 67651163709     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22476     Document Type: Letter

References (5)

1. Macdonell JE, Wrenn K. Hypothermia in the summer. South Med J 1991;84:804-805.
2. Tchoua R, Mahamat Y, Loembe PM. Hypothermie grave en milieu tropical. Med Trop 1998;58:158-160.
3. Collins GT, Newman AH, Grundt P, et al. Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists. Psychopharmacology 2007;193:159-170.
4. Ootsuka Y, Heidbreder CA, Hagan JJ, Blessing WW. Dopamine D2 receptor stimulation inhibits cold-initiated thermogenesis in brown adipose tissue in conscious rats. Neuroscience 2007;147: 127-135.
5. Hagg S, Mjorndal T. Repeated episodes of hypothermia in a subject treated with haloperidol, levomepromazine, olanzapine, and thioridazine. J Clin Psychopharmacol 2001;21:113-115.